Skip to main content

Research Repository

Advanced Search

Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation

Kiely, A P; Ling, H; Asi, Y T; Kara, E; Proukakis, C; Schapira, A H; Morris, H R; Lubbe, S; Limousin, P; Lewis, P A; Lees, A J; Quinn, N; Hardy, J; Love, S; Revesz, T; Houlden, H; Holton, J L

Authors

A P Kiely

H Ling

Y T Asi

E Kara

C Proukakis

A H Schapira

H R Morris

S Lubbe

P Limousin

P A Lewis

A J Lees

N Quinn

J Hardy

S Love

T Revesz

H Houlden

J L Holton



Abstract

We and others have described the neurodegenerative disorder caused by G51D SNCA mutation which shares characteristics of Parkinson’s disease (PD) and multiple system atrophy (MSA). The objective of this investigation was to extend the description of the clinical and neuropathological hallmarks of G51D mutant SNCA-associated disease by the study of two additional cases from a further G51D SNCA kindred and to compare the features of this group with a SNCA duplication case and a H50Q SNCA mutation case.

Citation

Kiely, A. P., Ling, H., Asi, Y. T., Kara, E., Proukakis, C., Schapira, A. H., …Holton, J. L. (2015). Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation. Molecular Neurodegeneration, 10, 41. https://doi.org/10.1186/s13024-015-0038-3

Journal Article Type Article
Acceptance Date Aug 13, 2015
Publication Date Aug 27, 2015
Deposit Date Jan 17, 2020
Publicly Available Date Mar 29, 2024
Journal Molecular Neurodegeneration
Publisher BioMed Central
Peer Reviewed Peer Reviewed
Volume 10
Pages 41
DOI https://doi.org/10.1186/s13024-015-0038-3
Public URL https://rvc-repository.worktribe.com/output/1399858

Files




You might also like



Downloadable Citations